0001209191-19-044238.txt : 20190802 0001209191-19-044238.hdr.sgml : 20190802 20190802161515 ACCESSION NUMBER: 0001209191-19-044238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190801 FILED AS OF DATE: 20190802 DATE AS OF CHANGE: 20190802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHIERMEIER ANDREW CENTRAL INDEX KEY: 0001738456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 19996167 MAIL ADDRESS: STREET 1: C/O INTELLIA THERAPEUTICS STREET 2: 40 ERIE STREET STE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-01 0 0001652130 Intellia Therapeutics, Inc. NTLA 0001738456 SCHIERMEIER ANDREW C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130 CAMBRIDGE MA 02139 0 1 0 0 EVP, Chief Operating Officer Stock Option (Right to Buy) 18.09 2019-08-01 4 A 0 55000 0.00 A 2029-07-31 Common Stock 55000 55000 D This option was granted on August 1, 2019 with respect to 55,000 shares of Common Stock, with 25% vesting on August 1, 2020 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter. /s/Jose Rivera, Attorney-In-Fact 2019-08-02